FCHL to Hold Extraordinary General Meeting on January 23, 2026
Globenewswire· 2025-12-31 18:22
Core Viewpoint - Fitness Champs Holdings Limited is set to hold an Extraordinary General Meeting (EGM) for shareholders on January 23, 2026, to discuss important resolutions [1][2]. Company Overview - Fitness Champs Holdings Limited is a prominent aquatic sports education provider in Singapore, offering swimming lessons for both children and adults, including ladies-only classes and aquatic sports such as water polo and competitive swimming [4]. - The company is recognized as one of the largest providers of swimming lessons to children in public schools through the SwimSafer program and has been providing private swimming lessons since 2012 [4]. - Fitness Champs aims to promote swimming as an enjoyable and affordable sport while focusing on water safety and fitness [4]. - The company plans to diversify its offerings by expanding into other sports, including pickleball [4]. EGM Details - The EGM will take place at 10 a.m. Singapore Time on January 23, 2026, at a specified location in Singapore [1]. - Shareholders listed in the register as of December 30, 2025, will be entitled to vote at the EGM [2]. - Relevant documents for the EGM, including the Notice, Proxy Statement, and Proxy Card, are available on the company's Investor Relations website and the SEC's website [3].
Copper Road Announces Closing of Second Tranche of Financing
Globenewswire· 2025-12-31 18:19
Core Viewpoint - Copper Road Resources Inc. has successfully closed the second and final tranche of its non-brokered private placement, raising a total of $539,640 through the sale of various units [1][3]. Group 1: Offering Details - The Offering consisted of the sale of 3,380,889 flow-through units at $0.045 each, 2,700,000 flow-through units at $0.05 each, and 6,312,500 hard-dollar units at $0.04 each [1]. - Each unit includes one common share and one common share purchase warrant, with warrants allowing the purchase of additional shares at $0.05 within 18 months [2]. Group 2: Use of Proceeds - Proceeds from the sale of flow-through units will be allocated to eligible Canadian exploration expenses, specifically for the exploration of the Ben Nevis Project and other Ontario properties [3]. Group 3: Related Party Transaction - A director of the Company subscribed for 1,111,111 flow-through units, which is classified as a related party transaction. The Company is exempt from formal valuation and minority shareholder approval requirements due to the participation's fair market value being under 25% of its market capitalization [4]. Group 4: Regulatory Approvals - The completion of the Offering is contingent upon receiving all necessary regulatory approvals, including from the TSX Venture Exchange. The issued securities will be subject to a statutory hold period of four months and one day [5]. Group 5: Finder's Fees - In connection with the closing of the Second Tranche, the Company will pay a cash commission of $33,000 to eligible finders and issue 100,000 finder warrants, each exercisable for a common share at $0.05 for 18 months [6].
BWR Exploration Inc. and Electro Metals and Mining Inc. Shareholders Approve Amalgamation and Provide Financing Update
Globenewswire· 2025-12-31 17:54
Core Viewpoint - BWR Exploration Inc. and Electro Metals and Mining Inc. have received shareholder approval for a proposed amalgamation involving a Reverse Takeover of BWR by Electro, expected to close around January 31, 2026 [1][7]. BWR Voting Results - A total of 32,800,400 common shares of BWR were represented at the AGM, accounting for approximately 29.68% of the 110,510,461 common shares outstanding [2]. - Shareholders voted 100% in favor of several resolutions, including the amalgamation, appointment of auditors, election of directors, and other corporate actions [3]. Electro Voting Results - Shareholders holding 29,319,119 common shares of Electro attended the AGM, representing about 76% of the 38,530,869 common shares outstanding [4]. - The shareholders also voted in favor of the amalgamation and other corporate actions, including the appointment of auditors and election of directors [4]. Concurrent Financing Update - Electro has closed the first tranches of a Concurrent Financing, issuing 777,689 FT Units for gross proceeds of $202,199 and 635,000 HD Units for gross proceeds of $127,000 [5]. - The financing aims to raise between $1.6 million and $2.25 million through FT Units priced at $0.26 and between $1.6 million and $1.75 million through HD Units priced at $0.20 [6]. Expected Closing of Transaction - The transaction is anticipated to close on or about January 31, 2026, alongside the closing of the Concurrent Financing, with free trading shares to be issued in the new company, Electro Metals Corp [7]. Transaction Terms - Under the transaction terms, BWR will issue one post-consolidation BWR share for each Electro share, implying a share price of $0.021 for each pre-consolidation BWR share [8]. Company Profiles - BWR Exploration Inc. is a Tier 2 junior exploration company with three early-stage exploration properties in Canada, requiring further exploration to meet current reporting standards [10]. - Electro Metals and Mining Inc. is a privately held company focused on the acquisition and exploration of precious and critical metals in Québec, with significant mineralization claims [11].
Independent Bank Corporation Announces Date for Its Fourth Quarter 2025 Earnings Release
Globenewswire· 2025-12-31 17:45
Core Viewpoint - Independent Bank Corporation is set to release its fourth quarter results for 2025 on January 22, 2026, at 8:00 am ET, with a conference call scheduled for 11:00 am ET on the same day to discuss the results [1][2]. Group 1: Company Overview - Independent Bank Corporation is a Michigan-based bank holding company with total assets of approximately $5.5 billion [3]. - The company operates a branch network across Michigan's Lower Peninsula through its state-chartered bank subsidiary, Independent Bank, which offers a full range of financial services including commercial banking, mortgage lending, investments, insurance, and title services [3]. - Founded in 1864 as First National Bank of Ionia, the company is committed to providing exceptional personal service and value to its customers, stockholders, and the communities it serves [3]. Group 2: Upcoming Events - The fourth quarter results will be available on the company's website in the "News" section of the "Investor Relations" area [1]. - Investors and analysts can access the conference call by registering through a provided link, which will give them a phone number and access code [2]. - A replay of the conference call webcast will be available until January 22, 2027 [2].
Globavend Holdings Limited Announces Pricing of $1.4 Million Registered Direct Offering
Globenewswire· 2025-12-31 17:29
Core Viewpoint - Globavend Holdings Limited has announced a public offering expected to generate approximately $1.4 million in gross proceeds, aimed at enhancing its working capital and general corporate purposes [1][2]. Group 1: Offering Details - The offering consists of 889,359 ordinary shares or pre-funded warrants, with an effective purchase price of $1.60 per share [2]. - The offering is anticipated to close on January 2, 2026, with Univest Securities, LLC serving as the sole placement agent [2]. Group 2: Company Overview - Globavend Holdings Limited is an emerging e-commerce logistics provider, offering end-to-end logistics solutions primarily in Hong Kong, Australia, and New Zealand [4]. - The company serves enterprise customers, including e-commerce merchants and platforms, facilitating business-to-consumer (B2C) transactions [4]. - Globavend provides integrated cross-border logistics services, including parcel drop-off, consolidation, air-freight forwarding, customs clearance, transportation, and final delivery [4].
Start of construction for the Artemisya hybrid cluster in Uzbekistan: storage and first wind phase
Globenewswire· 2025-12-31 17:15
Core Insights - Voltalia has commenced construction of the Artemisya hybrid cluster in Uzbekistan, which includes 100 megawatts of storage and 100 megawatts of wind capacity, marking a significant advancement in the country's energy storage infrastructure [1][3]. Group 1: Project Details - The Artemisya project consists of a 25-year electricity sales contract for solar and wind generation, alongside a 15-year contract for storage, which includes 126 megawatts of solar, 300 megawatts of wind, and 100 megawatts / 200 megawatt-hours of batteries [2]. - The first phase of Artemisya, which includes 100 megawatts / 200 megawatt-hours of storage and the initial 100-megawatt wind tranche, is set to be completed by 2027 following investment agreements signed on December 5, 2025 [3]. Group 2: Strategic Importance - The Artemisya hybrid cluster, located in the Bukhara region, aims to enhance the flexibility and reliability of Uzbekistan's power system, contributing to the national goal of achieving eight gigawatts of renewable capacity by 2026 and twelve gigawatts by 2030, while also significantly reducing CO₂ emissions [4]. Group 3: Company Commitment - Voltalia's CEO, Robert Klein, emphasized the company's commitment to supporting Uzbekistan's energy transition, highlighting the importance of hybrid solutions, including storage, in ensuring grid stability and optimizing renewable energy integration [5]. Group 4: Company Overview - Voltalia operates with a total capacity of 3.3 gigawatts in operation and under construction, alongside a project portfolio of 17.4 gigawatts under development, positioning itself as a key player in the renewable energy sector [6]. - The company employs over 2,000 staff across 20 countries, enabling it to provide comprehensive services to its clients globally [8].
Mortgage Rates Drop to Lowest Level in 2025
Globenewswire· 2025-12-31 17:00
Primary Mortgage Market Survey® U.S. weekly average mortgage rates as of 12/31/2025 MCLEAN, Va., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing the 30-year fixed-rate mortgage (FRM) averaged 6.15%. “After starting the year close to 7%, the average 30-year fixed-rate mortgage moved to its lowest level in 2025 this week, an encouraging sign for potential homebuyers heading into the new year,” said Sam Khater, F ...
Valneva and Serum Institute of India Announce Discontinuation of Chikungunya Vaccine License Agreement
Globenewswire· 2025-12-31 16:45
Core Insights - Valneva SE and Serum Institute of India have mutually agreed to discontinue their license agreement for Valneva's single-shot chikungunya vaccine, allowing Valneva to regain full rights and control over its supply chain and commercialization efforts in endemic high-risk countries [1][2] Group 1: Company Overview - Valneva SE is a specialty vaccine company focused on developing, manufacturing, and commercializing prophylactic vaccines for infectious diseases, addressing unmet medical needs [5] - The company has advanced multiple vaccines from early R&D to approvals and currently markets three proprietary travel vaccines [6] - Valneva's revenue from its growing commercial business supports the advancement of its vaccine pipeline, which includes a Lyme disease vaccine candidate partnered with Pfizer and a Shigella vaccine candidate [7] Group 2: Chikungunya Vaccine Context - Chikungunya virus (CHIKV) is a mosquito-borne disease causing severe joint pain, fever, and other symptoms, with significant economic and medical burdens expected to grow due to climate change [3][4] - Since 2004, chikungunya has spread to over 110 countries, with more than 3.7 million cases reported in the Americas between 2013 and 2023, highlighting the disease as a major public health problem according to the WHO [4] Group 3: Strategic Partnerships and Funding - Valneva's strategic intent to regain rights to the chikungunya vaccine aligns with its commitment to support access in low-and-middle-income countries, as outlined in a funding agreement with the Coalition for Epidemic Preparedness Innovations (CEPI) [2] - CEPI aims to accelerate vaccine development and ensure equitable access, having supported over 70 vaccine candidates against high-risk pathogens [8] Group 4: Serum Institute of India Overview - Serum Institute of India is a global leader in vaccine manufacturing, with an annual capacity of 4 billion doses and a presence in over 170 countries [10][11] - The company focuses on producing affordable vaccines and has played a significant role in reducing the prices of essential vaccines, including those for Diphtheria, Tetanus, and COVID-19 [11]
Casino Group: disposal of BAO Cash & Carry business
Globenewswire· 2025-12-31 16:30
Group 1 - Casino Group has announced the disposal of its BAO Cash & Carry business in Cameroon to 2S Retail, effective December 31, 2025 [2] - The transaction includes 7 sales outlets, with 5 integrated stores located in Douala and 2 franchised stores in Nkongsamba and Limbe [2] - This divestment aligns with Casino Group's strategy to partner with local entities for international brand development through franchising [2] Group 2 - BAO Cash & Carry, launched in 2018, has become a leading player in the wholesale business in Cameroon, serving over 3,000 active professional customers [3] - 2S Retail plans to maintain the low-cost business model that contributed to BAO Cash & Carry's success and is committed to preserving all existing jobs [4] - The new owner intends to consolidate the current business model in 2026, with plans for a new phase of development starting in 2027 [4]
Total number of shares and voting rights in Zealand Pharma as of December 31, 2025
Globenewswire· 2025-12-31 16:05
Core Viewpoint - Zealand Pharma A/S has reported the total number of shares and voting rights as of December 31, 2025, following a share capital increase due to the exercise of employee warrants [1][2]. Group 1: Share Capital and Voting Rights - As of December 31, 2025, Zealand Pharma has a total of 71,515,045 shares, with a nominal value of DKK 1 each, resulting in a share capital of DKK 71,515,045 and an equal number of voting rights [3]. Group 2: Company Overview - Zealand Pharma A/S is a biotechnology company focused on developing medicines for obesity and metabolic health, leveraging over 25 years of peptide R&D expertise and advanced data-driven approaches [4]. - The company has more than ten drug candidates that have entered clinical development, with two products already on the market and three candidates in late-stage development [4]. - Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in Boston, Massachusetts [4].